Literature DB >> 17973976

Multiple disease-linked myotubularin mutations cause NFL assembly defects in cultured cells and disrupt myotubularin dimerization.

Dmitry Goryunov1, Andrew Nightingale, Lorelei Bornfleth, Conrad Leung, Ronald K H Liem.   

Abstract

Charcot-Marie-Tooth disease (CMT) is an inherited peripheral neuropathy that has been linked to mutations in multiple genes. Mutations in the neurofilament light (NFL) chain gene lead to the CMT2E form whereas mutations in the myotubularin-related protein 2 and 13 (MTMR2 and MTMR13) genes lead to the CMT4B form. These two forms share characteristic pathological hallmarks on nerve biopsies including concentric sheaths ('onion bulbs') and, in at least one case, myelin loops. In addition, MTMR2 protein has been shown to interact physically with both NFL and MTMR13. Here, we present evidence that CMT-linked mutations of MTMR2 can cause NFL aggregation in a cell line devoid of endogenous intermediate filaments, SW13vim(-). Mutations in the protein responsible for X-linked myotubular myopathy (myotubularin, MTM1) also induced NFL abnormalities in these cells. We also show that two MTMR2 mutant proteins, G103E and R283W, are unable to form dimers and undergo phosphorylation in vivo, implicating impaired complex formation in myotubularin-related pathology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17973976     DOI: 10.1111/j.1471-4159.2007.05103.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

2.  The CMT4B disease-causing phosphatases Mtmr2 and Mtmr13 localize to the Schwann cell cytoplasm and endomembrane compartments, where they depend upon each other to achieve wild-type levels of protein expression.

Authors:  Aubree A Ng; Anne M Logan; Eric J Schmidt; Fred L Robinson
Journal:  Hum Mol Genet       Date:  2013-01-07       Impact factor: 6.150

3.  Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes.

Authors:  Darja Kanduc
Journal:  Biologics       Date:  2010-09-13

Review 4.  Dysfunctions of neuronal and glial intermediate filaments in disease.

Authors:  Ronald K H Liem; Albee Messing
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 5.  Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders.

Authors:  Zahra Alirezaei; Mohammad Hossein Pourhanifeh; Sarina Borran; Majid Nejati; Hamed Mirzaei; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.590

Review 6.  Charcot-Marie-Tooth disease and intracellular traffic.

Authors:  Cecilia Bucci; Oddmund Bakke; Cinzia Progida
Journal:  Prog Neurobiol       Date:  2012-03-22       Impact factor: 11.685

7.  Genotype-Phenotype Correlations in Charcot-Marie-Tooth Disease Due to MTMR2 Mutations and Implications in Membrane Trafficking.

Authors:  Haicui Wang; Ayşe Kaçar Bayram; Rosanne Sprute; Ozkan Ozdemir; Emily Cooper; Matthias Pergande; Stephanie Efthymiou; Ivana Nedic; Neda Mazaheri; Katharina Stumpfe; Reza Azizi Malamiri; Gholamreza Shariati; Jawaher Zeighami; Nurettin Bayram; Seyed Kianoosh Naghibzadeh; Mohamad Tajik; Mehmet Yaşar; Ahmet Sami Güven; Farah Bibi; Tipu Sultan; Vincenzo Salpietro; Henry Houlden; Hüseyin Per; Hamid Galehdari; Bita Shalbafan; Yalda Jamshidi; Sebahattin Cirak
Journal:  Front Neurosci       Date:  2019-10-14       Impact factor: 5.152

8.  A novel frameshift deletion in autosomal recessive SBF1-related syndromic neuropathy with necklace fibres.

Authors:  Qiang Gang; Conceição Bettencourt; Janice Holton; Christopher Lovejoy; Viorica Chelban; Emer Oconnor; Yun Yuan; Mary M Reilly; Michael Hanna; Henry Houlden
Journal:  J Neurol       Date:  2020-05-22       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.